May 16, 2017

Amyris On-Track To Double Revenue For Vitamin E Partnership With Nenter & Announces Exclusive Vitamin A License With Royal DSM

Amyris

EMERYVILLE, Calif., May 10, 2017 (GLOBE NEWSWIRE) — Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that it expects revenue related to its Vitamin E partnership with Nenter to more than double based on the current success of the program. During 2016, the company shipped approximately $9 million of farnesene to Nenter for conversion to Vitamin E and expects 2017 shipments to Nenter to be about $20 million.
Success with Nenter on Vitamin E
Amyris and Nenter have a strong partnership and commitment to grow together, supplying high performing Vitamin E oil to the global nutraceuticals market. The commercialization phase of this  partnership has started very strong and is an exclusive commitment between the two companies for the commercial production of Vitamin E.

Exclusive License Agreement with DSM on Vitamin A
The company also announced today that as part of its focus on growing its relationship with Koninklijke DSM N.V. (Royal DSM)(AEX:DSM.AS) it is entering into an exclusive licensing agreement for Vitamin A within the nutraceuticals market. This relationship is focused on a fast-track to market for the production and commercialization of low-cost supply of Vitamin A.

“Nenter’s investment and commitment to the Vitamin E market has proved to be an ideal partnership for growth by both companies,” said John Melo, Amyris President & CEO. “We are excited by their early commercialization results. This is a great example of combining our technology platform with their capabilities to deliver better chemistry. We plan to replicate this success with DSM on Vitamin A and expect a successful program and delivery of product before the end of 2019.”

About Amyris
Amyris is the integrated renewable products company that is enabling the world’s leading brands to achieve sustainable growth. Amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules and produce specialty ingredients and consumer products. The company is delivering its No Compromise® products across a number of markets, including specialty and performance chemicals, flavors and fragrances, cosmetics ingredients, pharmaceuticals, and nutraceuticals. More information about the company is available at www.amyris.com.

Source: http://investors.amyris.com/releasedetail.cfm?ReleaseID=1025792